Mergers & Acquisitions

By The Online Investor Staff, updated Thu., Aug. 6, 5:16 AM

This Slide: #2 of 100

Slide #2. R. & D. Biocogency Laboratories Inc. Ltd — Rafarma Pharmaceuticals, Inc.

Acquirer:	R. & D. Biocogency Laboratories Inc. Ltd
Acquiree:	Rafarma Pharmaceuticals, Inc. (RAFA)
Details:	Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has reached an agreement to be acquired by R. & D. Biocogency Laboratories Inc. Ltd ("Biocogency"). Under the agreed terms, Bio-cogency will acquire majority control of Rafarma Pharmaceuticals Inc. upon completion of Biocogency's transition to GAAP reporting standards and finalization of acquisition agreements.

R. & D. Biocogency Laboratories Inc. Ltd: PRIVATE
Rafarma Pharmaceuticals, Inc. : RAFA

« Back to slide 1

Continue to slide 3 »

Open the RAFA Page at The Online Investor (in a new window) »

RAFA — Current Quote

Quotes delayed 20 minutes

Mergers & Acquisitions Page | www.TheOnlineInvestor.com

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.